Current evidence supports ongoing GLP-1 therapy for cardiovascular risk reduction and glycemic control in these populations, making indefinite treatment medically sound rather than a failure to achieve independence
*Correspondence: Mizuki Ishiguro, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
How might focusing on BMI as a measure of obesity and health overlook other key factors contributing to cardiometabolic risks, and what alternative metrics could provide a more comprehensive evaluation
For in vitro research use only not for personal, cosmetic, or consumptive application
Frequently Asked Questions Microdosing GLP-1s means taking smaller doses of your prescribed medication
If you have a personal or family history of certain conditions, such as pancreatitis or medullary thyroid carcinoma, or are pregnant or breastfeeding, this treatment approach is not recommended for you
